Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype

Atherosclerosis

Volumn 131, Issue 2, 1997, Pages 257-262

  Luc, Gerald ^a   Ducimetiere, Pierre ^b   Bard, Jean Marie ^a   Arveiler, Dominique ^c   Evans, Alun ^d   Cambien, François ^b   Fruchart, Jean Charles ^a   Fievet, Catherine ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSERM   (France)

^c MONICA Project   (France)

^d Belfast MONICA Project   (United Kingdom)

Author keywords

Apo E Phenotype; Apolipoprotein E; HDL; IDL; LDL; VLDL

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ELECTROIMMUNOASSAY; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHENOTYPE; RISK FACTORS; TRIGLYCERIDES;

EID: 0030908461     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00053-1     Document Type: Article

References (27)

1. Zannis VI, Breslow JL, Utermann G et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 1982;23:911-914.
2. Mahley RW. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984;25:1277-1294.
3. Innerarity TL, Mahley RW. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry 1978;17:1440-1447.
4. Weisgraber KH. Apolipoprotein E: structure-function relationships. Adv Protein Chem 1994;45:249-302.
5. Gregg RE, Zech LA, Schaefer EJ, Brewer HB, Jr. Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. Science 1981;211:584-586.
6. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
7. Dallongeville J, Lussier Cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 1992;33:447-454.
8. Luc G, Bard JM, Arveiler D et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 1994;14:1412-1419.
9. Gibson JC, Rubinstein A, Bukberg PR, Brown WV. Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. J Lipid Res 1983;24:886-898.
10. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB, Jr. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 1986;78:815-821.
11. Steinmetz A, Jakobs C, Motzny S, Kaffarnik H. Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis 1989;9:405-411.
12. Parra HJ, Arveiler D et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 1992;12:701-707.
13. WHO Monica Project Principal Investigators. The World Health Organization MONICA Project (MONItoring trends and determinants in CArdiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105-114.
14. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353.
15. Luc G, Fievet C, Arveiler D et al. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: The ECTIM Study. J Lipid Res 1996;37:508-517.
16. Leroy A, Vu Dac N, Koffigan M, Clavey V, Fruchart JC. Characterization of a monoclonal antibody that binds to apolipoprotein E and to lipoprotein of human plasma containing apo E. Applications to ELISA quantification of plasma apo E. J Immunoassay 1988;9:309-334.
17. Menzel HJ, Utermann G. Apolipoprotein E phenotyping from serum Western blotting. Electrophoresis 1988;12:120-125.
18. Dong LM, Wilson C, Wardell MR et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 1994;269:22 358-22 365.
19. Weisgraber KH. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res 1990;31:1503-1511.
20. Cohn JS, Tremblay M, Amiot M et al. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler Thromb Vase Biol 1996;16:149-159.
21. Weisgraber KH, Mahley RW. Apoprotein (E-A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem 1978;253:6281-6288.
22. Weisgraber KH, Shinto LH. Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J Biol Chem 1991;266:12 029-12 034.
23. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
24. Mahley RW, Innerarity TL. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 1983;737:197-222.
25. Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 1982;257:2518-2521.
26. Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984;25:1017-1058.
27. Huang Y, Von Eckardstein A, Wu S, Maeda N, Assmann G. A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci USA 1994;91:1834-1838.